Cargando…

Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue?

Detalles Bibliográficos
Autores principales:	Nijholt, Kirsten Theresa, Westenbrink, Berend Daan, de Boer, Rudolf Allert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177477/ https://www.ncbi.nlm.nih.gov/pubmed/31868877 http://dx.doi.org/10.1093/cvr/cvz344

Ejemplares similares

Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?
por: Nijholt, Kirsten T., et al.
Publicado: (2022)

Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma
por: Palm, Constantin L., et al.
Publicado: (2022)

A Kinase Interacting Protein 1 regulates mitochondrial protein levels in energy metabolism and promotes mitochondrial turnover after exercise
por: Nijholt, Kirsten T., et al.
Publicado: (2023)

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020)

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
por: Yurista, Salva R., et al.
Publicado: (2020)

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
por: Nollet, Edgar E., et al.
Publicado: (2020)

The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise
por: Nijholt, Kirsten T., et al.
Publicado: (2021)

Nuclear Factor-κb to the Rescue of Cytokine-Induced Neuronal Survival
por: Ernfors, Patrik
Publicado: (2000)

I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway
por: Liu, Yafeng, et al.
Publicado: (2022)

Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy
por: Lorenzo, O., et al.
Publicado: (2011)

Titration of mitochondrial fusion rescues Mff-deficient cardiomyopathy
por: Chen, Hsiuchen, et al.
Publicado: (2015)

PGC-1α Agonist Rescues Doxorubicin-Induced Cardiomyopathy by Mitigating the Oxidative Stress and Necroptosis
por: Shipra, et al.
Publicado: (2023)

ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca(2+) Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ
por: Pavez-Giani, Mario G., et al.
Publicado: (2021)

Noninvasive Diagnosis of the Mitochondrial Function of Doxorubicin-Induced Cardiomyopathy Using In Vivo Dynamic Nuclear Polarization–Magnetic Resonance Imaging
por: Mizuta, Yukie, et al.
Publicado: (2022)

A Stem Cell-rescue Operation in a Nuclear Devastation
Publicado: (2011)

Highlight: Mitochondrial Mechanisms in Septic Cardiomyopathy
Publicado: (2015)

1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy
por: Zhuang, Qianqian, et al.
Publicado: (2023)

Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats
por: Ashour, Abdelkader E., et al.
Publicado: (2012)

AKIP1 Expression Modulates Mitochondrial Function in Rat Neonatal Cardiomyocytes
por: Yu, Hongjuan, et al.
Publicado: (2013)

Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial disease
por: Nishi, Masahiro, et al.
Publicado: (2020)

Nuclear Factor-κB Keeps Basal Cells Undifferentiated in Congenital Diaphragmatic Hernia
por: Varisco, Brian M.
Publicado: (2023)

Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure
por: Yurista, Salva R., et al.
Publicado: (2020)

Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
por: Abdullah, Chowdhury S., et al.
Publicado: (2019)

SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
por: Saucedo-Orozco, Huitzilihuitl, et al.
Publicado: (2022)

Bovine Model of Doxorubicin-Induced Cardiomyopathy
por: Bartoli, Carlo R., et al.
Publicado: (2011)

Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
por: Luu, Albert Z., et al.
Publicado: (2018)

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling
por: Nijholt, Kirsten T., et al.
Publicado: (2023)

DNase to the Rescue! Clearing Mitochondrial DNA May Have NET Benefits in Lung Transplantation
por: Juvet, Stephen, et al.
Publicado: (2020)

Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
por: Guo, Qian, et al.
Publicado: (2015)

Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy
por: Ta, Na, et al.
Publicado: (2022)

Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes
por: Mazzaccara, Cristina, et al.
Publicado: (2021)

Blockade of L-type Ca(2+) channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway
por: Ikeda, Soichiro, et al.
Publicado: (2019)

Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
por: Ezquer, Fernando, et al.
Publicado: (2015)

Homeopathy to the Rescue
Publicado: (1905)

Naproxen aggravates doxorubicin-induced cardiomyopathy in rats
por: Pathan, Rahila Ahmad, et al.
Publicado: (2010)

Potential Therapeutic Treatments for Doxorubicin-Induced Cardiomyopathy
por: Kabir, Shadman, et al.
Publicado: (2022)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

NF-κB and Disease
por: Poma, Paola
Publicado: (2020)

Metabolic rescue ameliorates mitochondrial encephalo‐cardiomyopathy in murine and human iPSC models of Leigh syndrome
por: Yoon, Jin‐Young, et al.
Publicado: (2022)

Systemic Bioinformatic Analyses of Nuclear-Encoded Mitochondrial Genes in Hypertrophic Cardiomyopathy
por: Tan, Zhaochong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qq22q5r88guu21mft4cr040pqr